Market Place
Sourcing Support
Enforcement Report - Week of June 26, 2024
26 Jun 2024 //
FDA
Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market
29 Apr 2024 //
BUSINESSWIRE
Shuangcheng`s Generic Eptifibatide receives Approval in the US
07 Sep 2021 //
FDA
Hybio`s Generic Eptifibatide Receive Approval in U.S
30 Mar 2020 //
FDA
Enforcement Report - Week of September 4, 2019
04 Sep 2019 //
FDA
Baxter International Nabs FDA Approval for Insulin IV Infusion
23 Jul 2019 //
BIOSPACE
Baxter Announces USFDA Approval of Ready-to-Use Cardiovascular Eptifibatide
06 Mar 2019 //
BUSINESSWIRE
Hainan Poly Pharm`s Generic Eptifibatide Receives Approval in US
25 Jan 2019 //
FDA
Celerity Pharms Generic Eptifibatide Receives Approval in US
27 Nov 2018 //
FDA
Accord Hlthcare’s Generics Eptifibatide Receives Approval In US
08 Nov 2017 //
FDA
Akorn`s Generic Eptifibatide Receives Approval In US
19 Apr 2017 //
FDA
Amneal`s Generic Eptifibatide Receives Approval In US
08 Dec 2016 //
FDA
Teva Recalls 4 Drugs Made at Banned Plant
15 Sep 2016 //
PHARMAMANUFACTURING
Aurobindo`s Generic Eptifibatide approved in US for Myocardial infarction
09 Dec 2015 //
FDA
Aurobindo gains strength after receiving USFDA nod for two products
09 Dec 2015 //
BUSINESS STANDARD
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.